AKT1 and esophageal squamous cell carcinoma: Overall, our study provides comprehensive knowledge of the lncRNA regulated Wnt/β-catenin and PI3K/Akt signaling pathways and highlights the potential of lncRNAs hindering the therapeutic efficacy in ESCC.